| scholarly article | Q13442814 |
| P2093 | author name string | B Sugden | |
| A L Kirchmaier | |||
| P2860 | cites work | Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. | Q38360539 |
| Plasmid maintenance of derivatives of oriP of Epstein-Barr virus | Q39868910 | ||
| Multiple regions within EBNA1 can link DNAs. | Q39872012 | ||
| Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines | Q39916460 | ||
| Establishment in continuous culture of a new type of lymphocyte from a “burkitt-like” malignant lymphoma (line d.g.-75) | Q40039870 | ||
| Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication | Q40116177 | ||
| Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells | Q40666871 | ||
| Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region | Q44286183 | ||
| The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication | Q45845623 | ||
| Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus | Q45854874 | ||
| Quantitative PCR: theoretical considerations with practical implications. | Q52389036 | ||
| A new dominant hybrid selective marker for higher eukaryotic cells | Q54533090 | ||
| A simple, rapid, and sensitive DNA assay procedure | Q56879279 | ||
| Electroporation: parameters affecting transfer of DNA into mammalian cells | Q69810864 | ||
| Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species | Q70540344 | ||
| Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA | Q24561747 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae | Q28265770 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB | Q33292465 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase | Q35235268 | ||
| An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene | Q35838226 | ||
| Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1). | Q36000904 | ||
| Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. | Q36634587 | ||
| The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter | Q36636897 | ||
| Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication | Q36648120 | ||
| Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. | Q36651288 | ||
| EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication | Q36656334 | ||
| Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. | Q36682530 | ||
| A chimera of EBNA1 and the estrogen receptor activates transcription but not replication | Q36693961 | ||
| Isolation of human sequences that replicate autonomously in human cells | Q36767535 | ||
| The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. | Q36806248 | ||
| A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. | Q36828303 | ||
| Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. | Q36828339 | ||
| Translational control of human cytomegalovirus gp48 expression | Q36828433 | ||
| A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus | Q36885800 | ||
| A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components | Q36891387 | ||
| trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. | Q36899288 | ||
| DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1 | Q37637173 | ||
| Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus | Q37637247 | ||
| Overexpression, Purification, and Crystallization of the DNA Binding and Dimerization Domains of the Epstein-Barr Virus Nuclear Antigen 1 | Q38292009 | ||
| The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. | Q38299741 | ||
| DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication | Q38329811 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1766-1775 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus | |
| P478 | volume | 71 |
| Q33702814 | Applications of oriP plasmids and their mode of replication |
| Q42244791 | Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing |
| Q41928227 | Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells |
| Q39530529 | Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids |
| Q97905739 | Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma |
| Q38613434 | Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization. |
| Q24610485 | Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma |
| Q24682422 | EBNA-1, a bifunctional transcriptional activator |
| Q43505203 | EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication |
| Q24675498 | EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes |
| Q90571096 | EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers |
| Q24517055 | EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. |
| Q47117102 | EBV and Apoptosis: The Viral Master Regulator of Cell Fate? |
| Q39091793 | Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes |
| Q90481228 | Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans |
| Q37125296 | Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q59351017 | Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus |
| Q28082701 | Epstein-Barr virus latent genes |
| Q36948327 | Epstein-Barr virus maintains lymphomas via its miRNAs. |
| Q33953070 | Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth |
| Q41594644 | Epstein-Barr virus oncogenesis |
| Q33716529 | Epstein-Barr virus provides a survival factor to Burkitt's lymphomas |
| Q39757202 | Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. |
| Q89971272 | Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3 |
| Q29617969 | Epstein-Barr virus: 40 years on |
| Q40445894 | Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. |
| Q42678529 | Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. |
| Q39459627 | Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event |
| Q33787020 | Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus |
| Q34348453 | Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. |
| Q34554716 | Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q30543103 | Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance |
| Q34992704 | Interaction of infectious spleen and kidney necrosis virus ORF119L with PINCH leads to dominant-negative inhibition of integrin-linked kinase and cardiovascular defects in zebrafish |
| Q33838228 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. |
| Q34667776 | Lymphomas differ in their dependence on Epstein-Barr virus |
| Q34107917 | Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. |
| Q36541024 | Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. |
| Q37060103 | Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection |
| Q28117643 | Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha |
| Q34353280 | Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential |
| Q39879541 | Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains |
| Q39580375 | Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. |
| Q34332147 | Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. |
| Q38166365 | The Epstein-Barr Virus EBNA1 Protein |
| Q37583383 | The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes |
| Q39604954 | The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon |
| Q34355092 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells |
| Q39445473 | The linking regions of EBNA1 are essential for its support of replication and transcription |
| Q40997583 | The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element |
| Q36756512 | The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. |
| Q34411851 | Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo |
| Q59332852 | Vasculogenic mimicry formation in EBV-associated epithelial malignancies |
| Q33466782 | Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1 |
Search more.